Cover Image

Potent CTL responses to conserved element of HIV to improve therapeutic DNA vaccine efficacy

Saved in:

Bibliographic Details
Main Authors:	B.K. Felber (Author), A. Valentin (Author), J.I. Mullins (Author), G.N. Pavlakis (Author)
Format:	Book
Published:	Elsevier, 2015-12-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

34 Novel conserved element HIV/SIV DNA vaccines maximize breadth and magnitude of immune response
by: B.K. Felber, et al.
Published: (2016)

HIV Env conserved element DNA vaccine alters immunodominance in macaques
by: Xintao Hu, et al.
Published: (2017)

Therapeutic conserved elements (CE) DNA vaccine induces strong T-cell responses against highly conserved viral sequences during simian-human immunodeficiency virus infection
by: Paul Munson, et al.
Published: (2018)

Gag and env conserved element CE DNA vaccines elicit broad cytotoxic T cell responses targeting subdominant epitopes of HIV and SIV Able to recognize virus-infected cells in macaques
by: Xintao Hu, et al.
Published: (2018)

HIV persistence despite reservoir decay during combinatorial immunotherapy including therapeutic conserved elements (CE) DNA vaccination, αPD-1 therapy, GS-986 TLR7-agonism, and CCR5 gene-edited CD4 T cell infusion in rhesus macaques
by: S. Dross, et al.
Published: (2019)

Myeloid-derived suppressor cells decrease T-cell responses to viral antigens and therapeutic conserved elements DNA vaccine and increase following analytic treatment interruption
by: S. Dross, et al.
Published: (2017)

OA4-1 Heterodimeric IL-15 induces effector cell activation and trafficking to the Germinal Centers of SIV infected Macaques
by: G.N. Pavlakis, et al.
Published: (2016)

Genetic diversity and CTL escape burden in the replication-competent HIV reservoir in youth in a therapeutic HIV vaccine trial
by: Z.L. Brumme, et al.
Published: (2017)

Immunogenicity and efficacy of DNA/MVA HIV vaccines in rhesus macaque models
by: Lynette Siv Chea, et al.
Published: (2017)

Space-Time Conservation Element and Solution Element Method Advances and Applications in Engineering Sciences
by: Wen, Chih-Yung
Published: (2023)

Space-Time Conservation Element and Solution Element Method Advances and Applications in Engineering Sciences /
by: Wen, Chih-Yung, et al.
Published: (2023)

Space-Time Conservation Element and Solution Element Method Advances and Applications in Engineering Sciences
by: Wen, Chih-Yung
Published: (2023)

Efficacy of conservative treatment of perianal abscesses in children and predictors for therapeutic failure
by: Lars Boenicke, et al.
Published: (2020)

Monoclonal antibodies as potent therapeutics in dentistry.
by: Pratichi Tripathi, et al.
Published: (2019)

PP 8.3 - 00049 Reduction in Markers of HIV Persistence with Gag/Pol/Il-12 DNA Therapeutic Vaccination
by: K. Chew, et al.
Published: (2022)

Functional profiling of HIV-specific CTL clonotypes and their ability to reduce HIV reservoir
by: N. Lima, et al.
Published: (2017)

B cell depletion alone or in combination with IL-15 or PD-1 blockade facilitates enhanced control of virus replication in SIV-infected rhesus macaques
by: L.J. Picker, et al.
Published: (2019)

20 Rapid CTL recognition of HIV-1 latently infected cells depends on the levels of inducible viral reactivation and CTL activation status
by: A. Ruiz, et al.
Published: (2017)

Therapeutic DNA vaccine encoding peptide P10 against experimental paracoccidioidomycosis.
by: Glauce M G Rittner, et al.
Published: (2012)

Therapeutic efficacy of a potent anti-Venezuelan equine encephalitis virus antibody is contingent on Fc effector function
by: Jennifer L. Schwedler, et al.
Published: (2024)

Ingenol derivatives are potent reactivators of latent HIV
by: V. Planelles, et al.
Published: (2015)

P4 Preclinical evaluation of an mRNA-based therapeutic HIV vaccine candidate combining rationally selected antigenic sequences and potent adjuvant signals (HTI-TriMix)
by: P. Tjok Joe, et al.
Published: (2016)

Testing the efficacy of a multi-component DNA-prime/DNA-boost vaccine against Trypanosoma cruzi infection in dogs.
by: José E Aparicio-Burgos, et al.
Published: (2011)

Immunogenicity of a PCR-based humanized HIV envelope DNA vaccine in mice
by: Sunee Sirivichayakul
Published: (2008)

Knowledge and professional practice on conservation of vaccines
by: Malena Almeida, et al.
Published: (2014)

Knowledge and professional practice on conservation of vaccines
by: Malena Almeida, et al.
Published: (2014)

Knowledge and professional practice on conservation of vaccines
by: Malena Almeida, et al.
Published: (2014)

Knowledge and professional practice on conservation of vaccines
by: Malena Almeida, et al.
Published: (2014)

Bacteriocin: A potent therapeutic weapon used as an alternative to antibiotics
by: Vidya Chauhan
Published: (2020)

Melatonin-A Potent Therapeutic for Stroke and Stroke-Related Dementia
by: Nadia Sadanandan, et al.
Published: (2020)

Advances in DNA Vaccines
Published: (2021)

PP 1.13 - 00078 CTL epitopes from structurally important hiv proteins are identified in rebound HIV
by: E. Lee, et al.
Published: (2022)

Intrinsic resistance of HIV-infected macrophages to CTL-mediated killing drives immune activation
by: K. Clayton, et al.
Published: (2017)

BCL-2 antagonism sensitises CTL-resistant HIV reservoirs to elimination ex vivo
by: R.B. Jones, et al.
Published: (2019)

Helminth coinfection does not affect therapeutic effect of a DNA vaccine in mice harboring tuberculosis.
by: Fabiani G Frantz, et al.
Published: (2010)

Novel dual role of dendritic cells in priming de novo CTL responses while inhibiting memory CTL responses to HIV-1 through the PD-L1 pathway
by: T.M. Garcia-Bates, et al.
Published: (2017)

Conserved metabolic enzymes as vaccine antigens for giardiasis.
by: Sozaburo Ihara, et al.
Published: (2022)

Conserved metabolic enzymes as vaccine antigens for giardiasis
by: Sozaburo Ihara, et al.
Published: (2022)

New challenges in therapeutic vaccines against HIV infection
by: Lorna Leal, et al.
Published: (2017)

Cytokines in Sepsis: Potent Immunoregulators and Potential Therapeutic Targets-An Updated View
by: Wibke Schulte, et al.
Published: (2013)